PATH.NYSEUipath, INC

Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


UiPath's CEO, Daniel Dines, executed a sale of 45,000 shares of Class A Common Stock at an average price of $12.0058, as part of a pre-arranged trading plan.

Summary

  • On May 1, 2025, Daniel Dines, the CEO and Chairman of UiPath, sold 45,000 shares of Class A Common Stock.
  • The sale was executed at a price of $12.0058 per share.
  • The transaction was conducted under a qualified selling plan (Rule 10b5-1).
  • Following the transaction, Mr. Dines directly owns 24,918,585 shares of Class A Common Stock.
  • Mr. Dines indirectly owns 240,000 shares through his spouse and 6,808,255 shares through Ice Vulcan Holding Limited.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transaction is a routine sale under a pre-arranged plan. It doesn't necessarily indicate a negative outlook on the company.

Positives

  • The sale was conducted under a pre-arranged 10b5-1 trading plan, which is often viewed as a way for insiders to sell shares without raising concerns about insider trading.

Negatives

  • The sale of shares by the CEO could be perceived negatively by some investors, although the existence of a 10b5-1 plan mitigates this concern.

Risks

  • While the sale is under a 10b5-1 plan, continued sales by insiders could put downward pressure on the stock price.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Insider transactions are common and closely monitored in the tech industry. Sales under 10b5-1 plans are a regular occurrence.

Comparison to Industry Standards

  • Comparing Daniel Dines's transactions to other tech CEOs' insider sales, the volume and frequency are within a typical range for executives managing their personal portfolios.
  • Similar to executives at companies like Snowflake or Datadog, Dines uses a 10b5-1 plan to manage sales, aligning with standard practices for maintaining transparency and avoiding market manipulation concerns.

Stakeholder Impact

  • The sale could have a minor impact on shareholder sentiment, but the existence of the 10b5-1 plan should mitigate concerns.

Key Dates

DateDescription
05/01/2025Date of the transaction (sale of shares) and filing of the Form 4.

Keywords

UiPath, Daniel Dines, insider trading, Form 4, stock sale, Rule 10b5-1, PATH, Class A Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.